Stay updated on BMS-986288 Immunotherapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986288 Immunotherapy Combo Clinical Trial page.

Latest updates to the BMS-986288 Immunotherapy Combo Clinical Trial page
- ChecktodayChange DetectedVersion 43 (Revision: v3.3.2) adds multiple study-content sections (Outcome Measures, Baseline Characteristics, Participant Flow, Study Status) and a QC status. It also includes dated entries (2025-11-20, 2025-12-04) and replaces Revision: v3.3.1.SummaryDifference0.6%

- Check14 days agoChange DetectedThe changes involve a site UI revision from version v3.2.0 to v3.3.1 on the page, with no changes to study data, records, or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedThe funding/operating status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check36 days agoChange DetectedAdverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and References were added to the study record. The page now shows an updated Study Status with a Quality Control Review indicated as Has Not Concluded.SummaryDifference0.7%

- Check65 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference10%

- Check72 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to BMS-986288 Immunotherapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986288 Immunotherapy Combo Clinical Trial page.